Rationalising fixed dose combinations for tuberculosis and acquired immunodeficiency syndrome therapy
Poorly managed healthcare can be directly attributed to extensive drug regimens. Numerous chronic illnesses and epidemics such as HIV/AIDS and tuberculosis require elaborate drug regimens for efficacious therapeutic outcomes. Various drug delivery systems have been developed to simplify their regimental drug therapy. However, more effective and innovative drug delivery technologies are required to increase patient compliance and provide controlled drug delivery. This review article attempts to provide a concise incursion into the use of fixed dose combinations as a strategy for drug delivery and describes the opportunities and challenges for the treatment of conditions that require chronic suppressive regimental drug therapy.
Keywords: fixed doses, fixed dose drug combinations, tuberculosis, human immunodeficiency virus, HIV, asthma, polymeric drug delivery, multiparticulates, liposomes, drug efficacy, targeted drug delivery, drug resistance, chronic suppressive regimental drug therapy
Customer comments
No comments were found for Rationalising fixed dose combinations for tuberculosis and acquired immunodeficiency syndrome therapy. Be the first to comment!